Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.

Abstract

In the present study we have developed lipid nanoparticle (LN) dispersions based on a multiple emulsion technique for encapsulation of hydrophilic drugs or/and proteins by a full factorial design. In order to increase ocular retention time and mucoadhesion by electrostatic attraction, a cationic lipid, namely cetyltrimethylammonium bromide (CTAB), was added in the lipid matrix of the optimal LN dispersion obtained from the factorial design. There are a limited number of studies reporting the ideal concentration of cationic agents in LN for drug delivery. This paper suggests that the choice of the concentration of a cationic agent is critical when formulating a safe and stable LN. CTAB was included in the lipid matrix of LN, testing four different concentrations (0.25%, 0.5%, 0.75%, or 1.0%wt) and how composition affects LN behavior regarding physical and chemical parameters, lipid crystallization and polymorphism, and stability of dispersion during storage. In order to develop a safe and compatible system for ocular delivery, CTAB-LN dispersions were exposed to Human retinoblastoma cell line Y-79. The toxicity testing of the CTAB-LN dispersions was a fundamental tool to find the best CTAB concentration for development of these cationic LN, which was found to be 0.5 wt% of CTAB.

DOI: 10.1016/j.ijpharm.2013.11.025

11 Figures and Tables

0502014201520162017
Citations per Year

56 Citations

Semantic Scholar estimates that this publication has 56 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Fangueiro2014DesignOC, title={Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.}, author={Joana F. Fangueiro and Tatiana Andreani and Maria Antonia Egea and Mar{\'i}a Luisa Serrano Garc{\'i}a and Selma B. Souto and Am{\'e}lia Maria Marinho de Morais e Silva and E. Souto}, journal={International journal of pharmaceutics}, year={2014}, volume={461 1-2}, pages={64-73} }